MitoRx Therapeutics
PrivateLast Round
Early Funding
Nov 17, 2025
Total Funding Raised
$12.24M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MitoRx Therapeutics is a biotechnology company developing innovative small molecule mitochondrial metabolic modulators for weight loss and metabolic disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MitoRx Therapeutics Comparables
Compare MitoRx Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NRG Therapeutics | 87% | |
| Mitondra Therapeutics | 83% | |
| Pretzel Therapeutics | 83% | |
MitoRx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Nov 17, 2025 | ||||
| Seed | Dec 13, 2023 | ||||
| Seed | Apr 25, 2022 |
MitoRx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oshen Holdings SA | Early Funding |
| Longevitytech.fund | Early Funding, Seed |
| UK Innovation & Science Seed Fund | Early Funding, Seed |
| Empirical Ventures | Early Funding |
| Wren Capital | Early Funding, Seed |
| Oxford Technology | Early Funding, Seed |
| Science Angels Syndicate | Early Funding, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2026
Presenting data at the American Diabetes Association 2026 conference in June.
- May 17, 2026
Monthly visitors increased 432% MoM.
MitoRx Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MitoRx Therapeutics's valuation, stock price, and market status.